Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：NCI-H2122 [H2122] Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F17
Human non-small cell lung cancer cell line
Strain Name：NCI-H522 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F26
Strain Name：NCI-H661 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F01
Human non-small-cell lung cancer cell lines
Strain Name：NCI-H1299 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F16
Strain Name：NCI-H1568 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F31
human non-small cell lung carcinoma cell line
Strain Name：NCI-H838 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F30
Strain Name：NCI-H2023 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F32
Strain Name：NCI-H1155 Strain State ： Construction | Cat. NO.：NMC-240401
human non-small cell lung cancer cell line
Strain Name：Calu-6 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-F12
CaLu-06 is a human lung adenocarcinoma cell line. This cell line was established in 1971 from lung metastasis in lung adenocarcinoma．
Strain Name：A549 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-F04A
A549 cells are isolated from the lung tissue of a 58-year-old Caucasian male with lung cancer.
Please fill in the order form and we will contact you within 2 working days.
